Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Treatment
17 results:

  • 1.
    Zhang L; Ji Q; Chen Q; Wei Z; Liu S; Zhang L; Zhang Y; Li Z; Liu H; Sui H
    Int J Biol Sci; 2023; 19(14):4393-4410. PubMed ID: 37781044
    [No Abstract]    [Full Text] [Related]  

  • 2. Vitamin D receptor prevents tumour development by regulating the Wnt/β-catenin signalling pathway in human colorectal cancer.
    Yu J; Sun Q; Hui Y; Xu J; Shi P; Chen Y; Chen Y
    BMC Cancer; 2023 Apr; 23(1):336. PubMed ID: 37046222
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon cancer.
    Xu M; Li Q; Zhang J; Xie H
    Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. lef1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan.
    Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L
    Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CREB1-induced lncRNA lef1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis.
    Cheng Y; Wu J; Qin B; Zou BC; Wang YH; Li Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):678-684. PubMed ID: 32248974
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
    Wang Z; Zhou L; Xiong Y; Yu S; Li H; Fan J; Li F; Su Z; Song J; Sun Q; Liu SS; Xia Y; Zhao L; Li S; Guo F; Huang P; Carson DA; Lu D
    Br J Pharmacol; 2019 Sep; 176(17):3390-3406. PubMed ID: 31236922
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-lef1/TSPAN8 Axis in colorectal cancer.
    Tanaka T; Kojima K; Yokota K; Tanaka Y; Ooizumi Y; Ishii S; Nishizawa N; Yokoi K; Ushiku H; Kikuchi M; Kojo K; Minatani N; Katoh H; Sato T; Nakamura T; Sawanobori M; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 May; 26(5):1401-1411. PubMed ID: 30706227
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of lef1-Mediated DCLK1 by Niclosamide Attenuates colorectal cancer Stemness.
    Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS
    Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation.
    Hsu HH; Chen MC; Day CH; Lin YM; Li SY; Tu CC; Padma VV; Shih HN; Kuo WW; Huang CY
    World J Gastroenterol; 2017 Feb; 23(7):1171-1179. PubMed ID: 28275297
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Topoisomerase IIα mediates TCF-dependent epithelial-mesenchymal transition in colon cancer.
    Zhou Q; Abraham AD; Li L; Babalmorad A; Bagby S; Arcaroli JJ; Hansen RJ; Valeriote FA; Gustafson DL; Schaack J; Messersmith WA; LaBarbera DV
    Oncogene; 2016 Sep; 35(38):4990-9. PubMed ID: 26947016
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The lef1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
    Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
    Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
    Shimomura A; Takasaki A; Nomura R; Hayashi N; Senda T
    Med Mol Morphol; 2013 Mar; 46(1):14-9. PubMed ID: 23325550
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Selective suicide gene therapy of colon cancer cell lines exploiting fibroblast growth factor 18 promoter.
    Teimoori-Toolabi L; Azadmanesh K; Zeinali S
    Cancer Biother Radiopharm; 2010 Feb; 25(1):105-16. PubMed ID: 20187803
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells.
    Bordonaro M; Lazarova DL; Sartorelli AC
    Nucleic Acids Res; 2004; 32(8):2660-74. PubMed ID: 15141037
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
    Kim K; Lee KY
    Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.